Rump Stephen L. Von insider trades: Medite Cancer Diagnostics (MDIT) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Rump reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jul 27, 2018 | MDIT | ↑ Buy | 133,333 | $0.07 | $10K | Direct | Jul 30, 2018 (3d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Rump Stephen L. Von's insider trades
Rump Stephen L. Von is CEO / CFO at Medite Cancer Diagnostics (MDIT). Since Jul 27, 2018, Rump has reported 1 open-market purchase worth $10K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MDIT insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.